Mustang Bio, Inc. (MBIO)Healthcare | Biotechnology | Waltham, United States | NasdaqCM
0.74 USD
-0.03
(-3.922%) ⇩
(April 20, 2026, 4 p.m.
EDT)
Short-term: ☆☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:11 a.m. EDT
Extreme bearish signal driven by deteriorating technicals and negative momentum; despite recent news of an FDA orphan drug designation, the forecasting model predicts a 12% decline over the next 45 days, and the stock remains deeply undervalued by fundamentals with no dividend support. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.078628 |
| AutoARIMA | 0.163057 |
| AutoETS | 0.164774 |
| MSTL | 0.173415 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 60% |
| H-stat | 0.21 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.007 |
| Excess Kurtosis | 1.26 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 5,605,817 |
| Forward P/E | -2.11 |
| Beta | 2.18 |
| Website | https://www.mustangbio.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.40322578 |
| Address1 | 95 Sawyer Road |
| Address2 | Suite 110 |
| All Time High | 10,012.5 |
| All Time Low | 0.531 |
| Ask | 0.917 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 37,390 |
| Average Daily Volume3 Month | 168,767 |
| Average Volume | 168,767 |
| Average Volume10Days | 37,390 |
| Beta | 2.18 |
| Bid | 0.525 |
| Bid Size | 2 |
| Book Value | 1.306 |
| City | Waltham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.7398 |
| Current Ratio | 2.223 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.77 |
| Day Low | 0.6774 |
| Display Name | Mustang Bio |
| Earnings Timestamp End | 1,755,288,000 |
| Earnings Timestamp Start | 1,754,942,400 |
| Ebitda | -2,398,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 4.863 |
| Enterprise Value | -11,660,715 |
| Eps Forward | -0.35 |
| Eps Trailing Twelve Months | -0.39 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.8563 |
| Fifty Day Average Change | -0.11650002 |
| Fifty Day Average Change Percent | -0.13605048 |
| Fifty Two Week Change Percent | -40.32258 |
| Fifty Two Week High | 7.0 |
| Fifty Two Week High Change | -6.2602 |
| Fifty Two Week High Change Percent | -0.8943143 |
| Fifty Two Week Low | 0.531 |
| Fifty Two Week Low Change | 0.20879996 |
| Fifty Two Week Low Change Percent | 0.39322025 |
| Fifty Two Week Range | 0.531 - 7.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,503,408,600,000 |
| Float Shares | 5,346,993 |
| Forward Eps | -0.35 |
| Forward P E | -2.1137142 |
| Free Cashflow | -4,149,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 4 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04298 |
| Held Percent Institutions | 0.10118 |
| Implied Shares Outstanding | 7,577,477 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,736,985,600 |
| Last Split Factor | 1:50 |
| Long Business Summary | Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children's hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts. |
| Long Name | Mustang Bio, Inc. |
| Market | us_market |
| Market Cap | 5,605,817 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_326621488 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -1,921,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 5,605,816 |
| Open | 0.75 |
| Operating Cashflow | -5,264,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 781 652 4500 |
| Previous Close | 0.77 |
| Price Hint | 4 |
| Price To Book | 0.56646246 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.209 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0302 |
| Regular Market Change Percent | -3.92208 |
| Regular Market Day High | 0.77 |
| Regular Market Day Low | 0.6774 |
| Regular Market Day Range | 0.6774 - 0.77 |
| Regular Market Open | 0.75 |
| Regular Market Previous Close | 0.77 |
| Regular Market Price | 0.7398 |
| Regular Market Time | 1,776,715,201 |
| Regular Market Volume | 106,559 |
| Return On Assets | -0.11301 |
| Return On Equity | -0.67928004 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 6,732,092 |
| Shares Percent Shares Out | 0.0166 |
| Shares Short | 125,433 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 133,993 |
| Short Name | Mustang Bio, Inc. |
| Short Percent Of Float | 0.0186 |
| Short Ratio | 3.41 |
| Source Interval | 15 |
| State | MA |
| Symbol | MBIO |
| Total Cash | 17,266,000 |
| Total Cash Per Share | 2.279 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.39 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.31042 |
| Two Hundred Day Average Change | -0.57062006 |
| Two Hundred Day Average Change Percent | -0.4354482 |
| Type Disp | Equity |
| Volume | 106,559 |
| Website | https://www.mustangbio.com |
| Zip | 2,453 |